Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$919M |
| 2 |
Tesla
TSLA
|
+$840M |
| 3 |
Visa
V
|
+$540M |
| 4 |
Amazon
AMZN
|
+$522M |
| 5 |
Broadcom
AVGO
|
+$449M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.26B |
| 2 |
Apple
AAPL
|
+$1.02B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$958M |
| 4 |
Microsoft
MSFT
|
+$904M |
| 5 |
Privia Health
PRVA
|
+$648M |
Sector Composition
| 1 | Technology | 20.52% |
| 2 | Financials | 9.9% |
| 3 | Healthcare | 9.56% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 6.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4426
VistaGen Therapeutics
VTGN
$110M
| $107K | ﹤0.01% |
57,316
+54,060
| +1,660% | +$101K |
|
4427
Foghorn Therapeutics
FHTX
$295M
| $107K | ﹤0.01% |
15,217
-15,858
| -51% | -$112K |
|
4428
Prelude Therapeutics
PRLD
$66.8M
| $107K | ﹤0.01% |
23,788
-25,708
| -52% | -$116K |
|
4429
ATAI Life Sciences
ATAI
$1.01B
| $107K | ﹤0.01% |
62,093
-35,158
| -36% | -$60.5K |
|
|
PLM
4430
DELISTED
PolyMet Mining Corp.
PLM
| $105K | ﹤0.01% |
133,184
+65,846
| +98% | +$52K |
|
4431
Actinium Pharmaceuticals
ATNM
$51.8M
| $103K | ﹤0.01% |
13,939
-79,176
| -85% | -$587K |
|
4432
ECARX Holdings
ECX
$630M
| $102K | ﹤0.01% |
+14,726
| New | +$102K |
|
|
APPH
4433
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $102K | ﹤0.01% |
276,352
+198,766
| +256% | +$73.5K |
|
4434
Reservoir Media
RSVR
$509M
| $101K | ﹤0.01% |
16,817
-25,711
| -60% | -$155K |
|
4435
Protalix BioTherapeutics
PLX
$136M
| $100K | ﹤0.01% |
+50,194
| New | +$100K |
|
4436
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$689M
| $99.8K | ﹤0.01% |
+843
| New | +$99.8K |
|
|
MSD
4437
Morgan Stanley Emerging Markets Debt Fund
MSD
$153M
| $99.8K | ﹤0.01% |
+15,500
| New | +$99.8K |
|
|
SFT
4438
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $99.3K | ﹤0.01% |
45,760
+4,468
| +11% | +$9.7K |
|
|
GRTX
4439
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $99.2K | ﹤0.01% |
31,802
+20,487
| +181% | +$63.9K |
|
4440
Similarweb
SMWB
$832M
| $97.8K | ﹤0.01% |
14,907
-18,631
| -56% | -$122K |
|
4441
Hycroft Mining Holding Corp
HYMC
$227M
| $96.4K | ﹤0.01% |
32,656
+26,280
| +412% | +$77.6K |
|
|
OMGA
4442
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $95.7K | ﹤0.01% |
17,082
-34,240
| -67% | -$192K |
|
4443
Mammoth Energy Services
TUSK
$113M
| $95.3K | ﹤0.01% |
19,728
-31,761
| -62% | -$153K |
|
|
USAS
4444
Americas Gold and Silver
USAS
$742M
| $95K | ﹤0.01% |
107,649
-9,397
| -8% | -$8.29K |
|
4445
Aquestive Therapeutics
AQST
$590M
| $94.3K | ﹤0.01% |
+57,149
| New | +$94.3K |
|
4446
Focus Universal
FCUV
$19M
| $94K | ﹤0.01% |
+6,145
| New | +$94K |
|
4447
Barnes & Noble Education
BNED
$287M
| $94K | ﹤0.01% |
746
-380
| -34% | -$47.9K |
|
|
NEWP
4448
New Pacific Metals
NEWP
$365M
| $92.9K | ﹤0.01% |
42,628
-2,389
| -5% | -$5.21K |
|
4449
Full House Resorts
FLL
$122M
| $92.8K | ﹤0.01% |
13,855
-6,826
| -33% | -$45.7K |
|
4450
Wallbox
WBX
$66.9M
| $92.7K | ﹤0.01% |
1,310
-4,437
| -77% | -$314K |
|